Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep;34(9):e465-e466.
doi: 10.1111/jdv.16661. Epub 2020 Jul 6.

COVID-19 in a melanoma patient under treatment with checkpoint inhibition

Affiliations
Case Reports

COVID-19 in a melanoma patient under treatment with checkpoint inhibition

P Schmidle et al. J Eur Acad Dermatol Venereol. 2020 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Timeline of the COVID‐19 disease course, cancer treatment, imaging results and SARS‐CoV‐2 tests.

References

    1. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China ‐ key questions for impact assessment. N Engl J Med 2020; 382: 692–694. - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239. - PubMed
    1. Li X, Xu S, Yu M et al. Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan. J Allergy Clin Immunol 2020. [Epub ahead or print] 10.1016/j.jaci.2020.04.006 - DOI - PMC - PubMed
    1. Tagliaferri L, Di Stefani A, Schinzari G et al. Skin cancer triage and management during COVID‐19 pandemic. J Eur Acad Dermatol Venereol 2020; 34: 1136–1139. - PMC - PubMed
    1. Vardhana SA, Wolchok JD. The many faces of the anti‐COVID immune response. J Exp Med 2020; 217: e20200678. - PMC - PubMed

Substances